Inter Parfums inks deal with Montblanc
This article was originally published in The Rose Sheet
Executive Summary
New York-based fragrance firm's Paris-based subsidiary, Inter Parfums SA, has entered into a license agreement to create, produce and distribute perfumes and ancillary products for Hamburg, Germany-based Montblanc International. Montblanc, best known for its high-quality pens, expanded into accessories such as watches and eyewear over the past few years. The license agreement is for 10.5 years and will take effect July 1. The partnership "will further strengthen Inter Parfums prospects for continued expansion in the selective perfume market," chairman and CEO Philippe Benacin said
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.